Free Trial

89bio (ETNB) Insider Trading & Ownership

89bio logo
$7.94 +0.91 (+12.94%)
(As of 12/20/2024 05:31 PM ET)

89bio (NASDAQ:ETNB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.80%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$20.93 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$48,172.52
Get ETNB Insider Trade Alerts

Want to know when executives and insiders are buying or selling 89bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ETNB Insider Buying and Selling by Quarter

89bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/6/2024Rohan PalekarCEOBuy5,000$7.89$39,450.00  
12/5/2024Charles McwherterDirectorBuy10,000$8.00$80,000.00  
11/22/2024Rohan PalekarCEOBuy10,000$8.35$83,500.00  
3/4/2024Ra Capital Management, L.P.DirectorBuy1,350,000$15.35$20,722,500.00  
2/26/2024Rohan PalekarCEOSell4,477$10.76$48,172.52  
(Data available from 1/1/2013 forward)

ETNB Insider Trading Activity - Frequently Asked Questions

The list of insiders at 89bio includes Charles Mcwherter, Edward Morrow Atkinson III, Kathleen Laporte, Michael R Hayden, Orbimed Advisors Llc, Quoc Le-Nguyen, Ra Capital Management, L.P., Ram Waisbourd, Rohan Palekar, and Ryan Martins. Learn more on insiders at ETNB.

2.80% of 89bio stock is owned by insiders. Learn more on ETNB's insider holdings.

The following insiders have purchased ETNB shares in the last 24 months: Charles Mcwherter ($80,000.00), Michael R Hayden ($1,016,463.70), Ra Capital Management, L.P. ($60,722,492.50), and Rohan Palekar ($122,950.00).

Insiders have purchased a total of 3,904,326 ETNB shares in the last 24 months for a total of $61,941,906.20 bought.

The following insiders have sold ETNB shares in the last 24 months: Edward Morrow Atkinson III ($111,937.50), Kathleen Laporte ($235,000.00), Quoc Le-Nguyen ($247,799.13), Rohan Palekar ($588,172.52), and Ryan Martins ($388,773.00).

Insiders have sold a total of 94,190 89bio shares in the last 24 months for a total of $1,571,682.15 sold.

89bio Key Executives

  • Mr. Rohan PalekarMr. Rohan Palekar (Age 58)
    CEO & Director
    Compensation: $1.06M
    2 recent trades
  • Mr. Quoc Le-Nguyen (Age 56)
    Chief Technical Operations Officer
    Compensation: $702.87k
  • Dr. Harry Mansbach M.D. (Age 59)
    Chief Medical Officer
    Compensation: $732.87k
  • Mr. Ryan Stephen Martins (Age 45)
    Chief Financial Officer
  • Mr. Shiva K. Natarajan CPA (Age 58)
    Senior Vice President of Finance & Principal Accounting Officer
  • Ms. Annie J. Chang M.B.A.
    VP of Investor Relations & Corporate Communications
  • Ms. Amanda Kurihara
    Vice President of People & Culture
  • Ms. Melissa Abel
    Senior Vice President of Commercial Strategy
  • Mr. Paul Shin
    Senior Vice President of R&D Operations
  • Mr. Michael Baldwin
    VP & Head of Quality


This page (NASDAQ:ETNB) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners